Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
NOVARTIS AG, set to beat Kite Pharma Inc to the finish line in one of the most promising new areas of cancer research, is examining how to price a revolutionary therapy patients will need to take just once.
The US Food and Drug Administration is likely to rule in early...